Natalie B. Collins
- Oncology top 5%
- Immunology top 5%
- Molecular Biology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- W. Nicholas HainingRobert T. MangusoVikram R. JunejaArlene H. SharpeMartin W. LaFleurGordon J. FreemanKathleen A. McGuireKevin Bi
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)CAR-T cell therapy research (4 papers)Neuroblastoma Research and Treatments (4 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Natalie B. Collins
20 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 963
- Immunology 826
- Molecular Biology 775
- Cancer Research 189
- Pulmonary and Respiratory Medicine 162
Countries citing papers authored by Natalie B. Collins
This map shows the geographic impact of Natalie B. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie B. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie B. Collins more than expected).
Fields of papers citing papers by Natalie B. Collins
This network shows the impact of papers produced by Natalie B. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie B. Collins. The network helps show where Natalie B. Collins may publish in the future.
Co-authorship network of co-authors of Natalie B. Collins
This figure shows the co-authorship network connecting the top 25 collaborators of Natalie B. Collins. A scholar is included among the top collaborators of Natalie B. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie B. Collins. Natalie B. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 47 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 36 | |
| 10 | 12 | |
| 11 | 13 | |
| 12 | 64 | |
| 13 | 13 | |
| 14 | 4 | |
| 15 | In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetbreakdown → | 774 |
| 16 | PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicitybreakdown → | 612 |
| 17 | 2 | |
| 18 | 66 | |
| 19 | 21 | |
| 20 | 4 |
About Natalie B. Collins
Natalie B. Collins is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Immunology (826 citations), Oncology (963 citations) and Cancer Research (189 citations). Natalie B. Collins has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include W. Nicholas Haining, Robert T. Manguso, Vikram R. Juneja, Arlene H. Sharpe, Martin W. LaFleur, Gordon J. Freeman, Kathleen A. McGuire, Kevin Bi, Brian C. Miller and Kathleen B. Yates. Their work appears in journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.